Stocks
Kyntra Bio, Inc.KYNB
NASDAQHealthcareBiotechnology$4.58
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing targeted therapies for rare and serious diseases, with a focus on genetic medicines. Its pipeline includes investigational candidates in early-stage trials, and investors track it for potential data readouts and partnership opportunities.
52W Range: $4.56-$11.39
Congressional Interest in Kyntra Bio, Inc. (KYNB)
No congressional trades have been disclosed for Kyntra Bio, Inc. (KYNB) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading KYNB?
No congressional trades found for this stock.